| 臺大學術典藏 |
2022-03-22T08:28:58Z |
Manufacturing and characterization of three-axis magnetic sensors using the standard 180 nm cmos technology
|
Wu C.-H;Shih P.-J;Tsai Y.-C;Dai C.-L.; Wu C.-H; Shih P.-J; Tsai Y.-C; Dai C.-L.; PO-JEN SHIH |
| 臺大學術典藏 |
2022-03-14T07:00:26Z |
Randomized controlled trial of probiotic ps128 in children with tourette syndrome
|
Wu C.-C.; Wong L.-C.; Hsu C.-J.; Yang C.-W.; Tsai Y.-C.; Cheng F.-S.; Hu H.-Y.; WANG-TSO LEE |
| 臺大學術典藏 |
2022-03-10T05:59:42Z |
Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: A potential regulator of adipogenesis
|
YI-CHENG CHANG; Liu P.-H.; Tsai Y.-C.; Chiu Y.-F.; Shih S.-R.; Ho L.-T.; Lee W.-J.; Lu C.-H.; Quertermous T.; Curb J.D.; Lee W.-J.; Lee P.-C.; He Y.-H.; Yeh J.-I.; Hwang J.-J.; Tsai S.-H.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T05:59:41Z |
Erratum: Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: A potential regulator of adipogenesis (Journal of Molecular Medicine DOI: 10.1007/s00109-012-0898-8)
|
YI-CHENG CHANG; Liu P.-H.; Tsai Y.-C.; Chiu Y.-F.; Shih S.-R.; Ho L.-T.; Lee W.-J.; Lu C.-H.; Quertermous T.; Curb J.D.; Lee W.-J.; Lee P.-C.; He Y.-H.; Yeh J.-I.; Hwang J.-J.; Tsai S.-H.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T05:59:39Z |
Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients
|
Yun-Chia Chang E.; Tsai S.-H.; Shun C.-T.; Hee S.-W.; YI-CHENG CHANG; Tsai Y.-C.; Tsai J.-S.; Chen H.-J.; Chou J.-W.; Lin S.-Y.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T05:59:38Z |
Knockdown of RyR3 enhances adiponectin expression through an atf3-dependent pathway
|
Tsai S.-H.; Chang E.Y.-C.; YI-CHENG CHANG; Hee S.-W.; Tsai Y.-C.; Chang T.-J.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T03:55:03Z |
Quantitative examination of early diabetes by light-emitting diodes light-induced pupillary light reflex
|
Yan Y.J.; Tsai Y.C.; Ko M.L.; NI-CHUNG LEE; Chiou J.C.; Ou-Yang M. |
| 臺大學術典藏 |
2022-03-04T05:33:47Z |
Response of refractory osteosarcoma to thalidomide and celecoxib
|
Tsai Y.-C.; CHEN-TU WU; Hong R.-L. |
| 臺大學術典藏 |
2022-03-04T03:48:19Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.; Tsai Y.-C.; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; WEI-CHOU LIN; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:18Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; WEI-CHOU LIN; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:16Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; WEI-CHOU LIN; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:13Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:06Z |
Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success
|
Peng K.-Y.; Liao H.-W.; Chan C.-K.; WEI-CHOU LIN; Yang S.-Y.; Tsai Y.-C.; Huang K.-H.; Lin Y.-H.; Chueh J.S.; Wu V.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:37Z |
Decreased expressions of hepsin in human hepatocellular carcinomas
|
CHIEN-HUNG CHEN; Su K.-Y.; Tao M.-H.; Lin S.-W.; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-22T05:34:31Z |
Decreased expressions of hepsin in human hepatocellular carcinomas
|
CHIEN-HUNG CHEN; Su K.-Y.; Tao M.-H.; Lin S.-W.; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-15T03:45:38Z |
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
|
Chan C.-K.; Chang Y.-Y.; Tsai Y.-C.; ZHENG-WEI CHEN; Wu C.-Y.; Huang W.-C.; Yen I.-W.; Wu K.-H.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; Lin L.-Y.; Hu F.-C.; Chang C.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Jeff Chueh S.-C.; Liao S.-C.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-01-25T05:10:36Z |
Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children
|
Huang H.-P.; Hsu H.-Y.; CHI-LING CHEN; Ni Y.-H.; Wang H.-Y.; Tsuei D.-J.; Chiang C.-L.; Tsai Y.-C.; Chen H.-L.; Chang M.-H. |
| 臺大學術典藏 |
2022-01-21T02:51:53Z |
Randomized controlled trial of probiotic ps128 in children with tourette syndrome
|
Wu C.-C.; LEE-CHIN WONG; Hsu C.-J.; Yang C.-W.; Tsai Y.-C.; Cheng F.-S.; Hu H.-Y.; Lee W.-T. |
| 臺大學術典藏 |
2022-01-14T03:59:35Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
Chen J.L.-Y.; JO-PAI CHEN; Huang Y.-S.; Tsai Y.-C.; Tsai M.-H.; Jaw F.-S.; Cheng J.C.-H.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2022-01-11T06:49:33Z |
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
|
HSIEN-YI CHIU; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:31Z |
Psoriasis in Taiwan: From epidemiology to new treatments
|
HSIEN-YI CHIU; Wang T.-S.; Chen P.-H.; Hsu S.-H.; Tsai Y.-C.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:26Z |
Measurement and prediction of the severity of postinflammatory dyspigmentation after resolution of psoriatic plaques in patients treated with biologic therapy
|
HSIEN-YI CHIU; Chang Liao N.-F.; Hui R.C.-Y.; Lin Y.-J.; Tsai Y.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2022-01-03T05:49:24Z |
Is the new comer always better?
|
Tsai Y.-C.; SHIH-CHIEH CHUEH |
| 臺大學術典藏 |
2022-01-03T05:49:22Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; SHIH-CHIEH CHUEH; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
